Fundraising Fox

Healthtech Late Stage Investors & VC Firms

847 firms in this list, with a median first check of $1M. 197 of them lead rounds. Generated from verified public data and updated continuously.

Georgian
Toronto, OntarioSeries B–Late Stage$25M – $100M
11 people
OCV Partners
Los AngelesPre-Seed–Late Stage
5 people
Romulus Capital
BostonSeed–Late Stage$250K – $10M
8 people
Vantage Capital
JohannesburgGrowth–Late Stage
8 people
Vesalius Biocapital Partners
LuxembourgSeed–Late Stage$11M
5 people
Bombora
SydneySeed–Late Stage
9 people
Endeavour Vision
GenevaLate Stage
6 people
Finchley Healthcare Ventures
MontrealSeed–Late Stage
11 people
N-Vest Venture
BangkokPre-Seed–Late Stage$1M – $7.4M
8 people
naturalX Health Ventures
KarlsruheSeed–Late Stage$3.2M – $5.4M
5 people
Panakes Partners
MilanSeed–Late Stage
11 people
Qazaqstan Investment Corporation
AstanaSeed–Late Stage
8 people
Syridex Bio
PrincetonPre-Seed–Late Stage
11 people
H Venture Partners
CincinnatiSeed–Late Stage$250K – $5M
2 people
First Ascent Ventures
TorontoSeries A–Late Stage$3.6M – $7.3M
7 people
iNetworks
PittsburghSeed–Late Stage
9 people
KIC Ventures
Fort LauderdaleSeed–Late Stage
9 people
Australis Partners
New YorkGrowth–Late Stage
8 people
Clal Biotechnology Industries
Tel AvivSeed–Late Stage
8 people
JSD Capital, LLC
New YorkSeed–Late Stage$10M
8 people
Ombu Group
LondonSeries A–Late Stage
8 people
Kern Capital, LLC
LarkspurSeed–Late Stage$5M – $15M
1 person
Grayhawk Capital
ScottsdaleSeries A–Late Stage
10 people
Pappas Capital
Research Triangle ParkSeed–Late Stage$100K – $6M
7 people

Related lists

Data sourced from public filings and firms' own websites — see our methodology.